AA
AMED

ALPS Advisors’s Amedisys AMED Stock Holding History

ALPS Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,093
Closed -$321K – 865
2020
Q4 		$321K Sell
1,093
-34
-3% -$8.72K ﹤0.01% 666
2020
Q3 		$266K Sell
1,127
-194
-15% -$44.1K ﹤0.01% 653
2020
Q2 		$262K Sell
1,321
-150
-10% -$28K ﹤0.01% 613
2020
Q1 		$270K Sell
1,471
-1,172
-44% -$209K ﹤0.01% 515
2019
Q4 		$441K Sell
2,643
-114
-4% -$17K ﹤0.01% 525
2019
Q3 		$361K Sell
2,757
-393
-12% -$51.2K ﹤0.01% 623
2019
Q2 		$382K Sell
3,150
-167
-5% -$19.8K ﹤0.01% 691
2019
Q1 		$409K Buy
+3,317
New +$416K ﹤0.01% 653

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ALPS Advisors's AMED Position: Q1 2021 in Review

ALPS Advisors sold out of Amedisys (AMED) in Q1 2021, closing a stake of 1,093 shares — an estimated $321K sold.

ALPS Advisors first reported a position in AMED in Q1 2019 and held it in 8 quarters. The position peaked at $441K in Q4 2019. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • ALPS Advisors reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • ALPS Advisors sold 1,093 Amedisys shares in Q1 2021, an estimated $321K.
  • ALPS Advisors first reported a position in Amedisys in Q1 2019 and held it in 8 quarters.
  • ALPS Advisors's Amedisys position peaked at $441K in Q4 2019.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on ALPS Advisors's 13F filing for Q1 2021, filed 7 May 2021.